The Supreme Court on Thursday ruled a group of doctors lacked legal standing to challenge the Food and Drug Administration’s regulation of the abortion pill mifepristone, keeping status quo on the medication.
The unanimous opinion was authored by Justice Brett Kavanaugh.
The case put abortion access back in the spotlight for the court after its conservative majority voted to overrule Roe v. Wade in 2022.
“Plaintiffs are pro-life, oppose elective abortion, and have sincere legal, moral, ideological, and policy objections to mifepristone being prescribed and used by others,” Kavanaugh wrote in the ruling. “Because plaintiffs do not prescribe or use mifepristone, plaintiffs are unregulated parties who seek to challenge FDA’s regulation of others.”
“Plaintiffs advance several complicated causation theories to connect FDA’s actions to the plaintiffs’ alleged injuries in fact. None of these theories suffices to establish Article III standing,” he concluded.
This is a developing story. Please check back for updates.